Phage M198 and Its Therapeutic Potential

Overview

Journal Viruses

Publisher MDPI

Date 2025 Jan 25

PMID 39861904

Authors

Lika Leshkasheli

Ia Kusradze

Darejan Bolkvadze

Lia Askilashvili

Maria Chichashvili

Giorgi Tsertsvadze

Elisabed Zaldastanishvili

Affiliations

Soon will be listed here.

Abstract

The rapid worldwide spread of antibiotic resistance is quickly becoming an increasingly concerning problem for human healthcare. Non-antibiotic antibacterial agents are in high demand for many Gram-negative bacterial pathogens, including . -targeting phages are among the most promising alternative therapy options. They have already been successfully applied in a number of cases, and it is expected that the need for anti- phages will only increase in the future. This prospect highlights the need for well-characterized therapeutic phages. In this work, we describe a phage, which also infects strains of . Here, we characterize phage M198 in terms of its biological and genetic properties. Since in some phage therapy cases, phages are administered in combination with antibiotics, here, we also screen for possible synergistic effects of combining phage M198 with six different antibiotics. We found that phage M198 has good lytic activity against clinical isolates; it does not have any indications of a temperate lifestyle, and it has synergistic potential when combined with some therapeutically relevant antibiotics.

References

Onallah H, Hazan R, Nir-Paz R . Compassionate Use of Bacteriophages for Failed Persistent Infections During the First 5 Years of the Israeli Phage Therapy Center. Open Forum Infect Dis. 2023; 10(5):ofad221. PMC: 10205549. DOI: 10.1093/ofid/ofad221. View

Gordillo Altamirano F, Barr J . Phage Therapy in the Postantibiotic Era. Clin Microbiol Rev. 2019; 32(2). PMC: 6431132. DOI: 10.1128/CMR.00066-18. View

. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024; 404(10459):1199-1226. PMC: 11718157. DOI: 10.1016/S0140-6736(24)01867-1. View

Abedon S . Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?. Antibiotics (Basel). 2019; 8(4). PMC: 6963693. DOI: 10.3390/antibiotics8040182. View

Easwaran M, De Zoysa M, Shin H . Application of phage therapy: Synergistic effect of phage EcSw (ΦEcSw) and antibiotic combination towards antibiotic-resistant Escherichia coli. Transbound Emerg Dis. 2020; 67(6):2809-2817. DOI: 10.1111/tbed.13646. View

Holt K, Wertheim H, Zadoks R, Baker S, Whitehouse C, Dance D . Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015; 112(27):E3574-81. PMC: 4500264. DOI: 10.1073/pnas.1501049112. View

Eskenazi A, Lood C, Wubbolts J, Hites M, Balarjishvili N, Leshkasheli L . Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat Commun. 2022; 13(1):302. PMC: 8766457. DOI: 10.1038/s41467-021-27656-z. View

Brussow H . The antibiotic resistance crisis and the development of new antibiotics. Microb Biotechnol. 2024; 17(7):e14510. PMC: 11226406. DOI: 10.1111/1751-7915.14510. View

Yoon S, Ha S, Lim J, Kwon S, Chun J . A large-scale evaluation of algorithms to calculate average nucleotide identity. Antonie Van Leeuwenhoek. 2017; 110(10):1281-1286. DOI: 10.1007/s10482-017-0844-4. View

10.

North O, Brown E . Phage-antibiotic combinations: a promising approach to constrain resistance evolution in bacteria. Ann N Y Acad Sci. 2020; 1496(1):23-34. DOI: 10.1111/nyas.14533. View

11.

Strathdee S, Hatfull G, Mutalik V, Schooley R . Phage therapy: From biological mechanisms to future directions. Cell. 2023; 186(1):17-31. PMC: 9827498. DOI: 10.1016/j.cell.2022.11.017. View

12.

Townsend E, Kelly L, Gannon L, Muscatt G, Dunstan R, Michniewski S . Isolation and Characterization of Phages for Phage Therapy. Phage (New Rochelle). 2021; 2(1):26-42. PMC: 8006926. DOI: 10.1089/phage.2020.0046. View

13.

Gu J, Liu X, Li Y, Han W, Lei L, Yang Y . A method for generation phage cocktail with great therapeutic potential. PLoS One. 2012; 7(3):e31698. PMC: 3291564. DOI: 10.1371/journal.pone.0031698. View

14.

Conly J, Johnston B . Where are all the new antibiotics? The new antibiotic paradox. Can J Infect Dis Med Microbiol. 2007; 16(3):159-60. PMC: 2095020. DOI: 10.1155/2005/892058. View

15.

Chan P, Lowe T . tRNAscan-SE: Searching for tRNA Genes in Genomic Sequences. Methods Mol Biol. 2019; 1962:1-14. PMC: 6768409. DOI: 10.1007/978-1-4939-9173-0_1. View

16.

Ikhimiukor O, Souza S, Akintayo I, Marcovici M, Workman A, Martin I . Phylogenetic lineages and antimicrobial resistance determinants of clinical spanning local to global scales. Microbiol Spectr. 2023; :e0054923. PMC: 10581156. DOI: 10.1128/spectrum.00549-23. View

17.

Manohar P, Madurantakam Royam M, Loh B, Bozdogan B, Nachimuthu R, Leptihn S . Synergistic Effects of Phage-Antibiotic Combinations against . ACS Infect Dis. 2022; 8(1):59-65. DOI: 10.1021/acsinfecdis.1c00117. View

18.

Carver T, Harris S, Berriman M, Parkhill J, McQuillan J . Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics. 2011; 28(4):464-9. PMC: 3278759. DOI: 10.1093/bioinformatics/btr703. View

19.

Gu Liu C, Green S, Min L, Clark J, Salazar K, Terwilliger A . Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020; 11(4). PMC: 7407087. DOI: 10.1128/mBio.01462-20. View

20.

Kutter E . Phage host range and efficiency of plating. Methods Mol Biol. 2008; 501:141-9. DOI: 10.1007/978-1-60327-164-6_14. View